These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3023102)
21. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Ho DD; Kaplan JC; Rackauskas IE; Gurney ME Science; 1988 Feb; 239(4843):1021-3. PubMed ID: 2830667 [TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120. Sun NC; Ho DD; Sun CR; Liou RS; Gordon W; Fung MS; Li XL; Ting RC; Lee TH; Chang NT J Virol; 1989 Sep; 63(9):3579-85. PubMed ID: 2474670 [TBL] [Abstract][Full Text] [Related]
23. Neutralizing monoclonal antibodies to the AIDS virus. Thomas EK; Weber JN; McClure J; Clapham PR; Singhal MC; Shriver MK; Weiss RA AIDS; 1988 Feb; 2(1):25-9. PubMed ID: 2451922 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus. Gosting LH; McClure J; Dickinson ES; Watanabe SM; Shriver K; Goldstein LC J Clin Microbiol; 1987 May; 25(5):845-8. PubMed ID: 2438302 [TBL] [Abstract][Full Text] [Related]
25. Certain human Gp120-HIV antibodies react with anti-CD4 antibodies. Lundin K; Karlsson A; Nygren A; Löfström A; Gigliotti D; Wigzell H Scand J Immunol; 1988 Jan; 27(1):113-7. PubMed ID: 2829345 [TBL] [Abstract][Full Text] [Related]
26. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Lyerly HK; Matthews TJ; Langlois AJ; Bolognesi DP; Weinhold KJ Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4601-5. PubMed ID: 3037522 [TBL] [Abstract][Full Text] [Related]
27. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037 [TBL] [Abstract][Full Text] [Related]
28. Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. Ferns RB; Tedder RS; Weiss RA J Gen Virol; 1987 Jun; 68 ( Pt 6)():1543-51. PubMed ID: 2438375 [TBL] [Abstract][Full Text] [Related]
29. Human monoclonal antibody against glycoproteins of human immunodeficiency virus. Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963 [TBL] [Abstract][Full Text] [Related]
30. Sensitive ELISA for the gp120 and gp160 surface glycoproteins of HIV-1. Moore JP; Jarrett RF AIDS Res Hum Retroviruses; 1988 Oct; 4(5):369-79. PubMed ID: 2848557 [TBL] [Abstract][Full Text] [Related]
31. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528 [TBL] [Abstract][Full Text] [Related]
32. Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein. Matthews TJ; Langlois AJ; Robey WG; Chang NT; Gallo RC; Fischinger PJ; Bolognesi DP Haematol Blood Transfus; 1987; 31():414-22. PubMed ID: 2832276 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. Gnann JW; Schwimmbeck PL; Nelson JA; Truax AB; Oldstone MB J Infect Dis; 1987 Aug; 156(2):261-7. PubMed ID: 2439614 [TBL] [Abstract][Full Text] [Related]
34. Replication of human immunodeficiency virus in two T-cell lines and their application as antigens for immunofluorescence. Kawatani T; Hattori N; Kurimura T Microbiol Immunol; 1988; 32(5):491-8. PubMed ID: 3050377 [TBL] [Abstract][Full Text] [Related]
35. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877 [TBL] [Abstract][Full Text] [Related]
36. HIV envelope-CD4 interaction not inhibited by synthetic octapeptides. Sodroski J; Kowalski M; Dorfman T; Basiripour L; Rosen C; Haseltine W Lancet; 1987 Jun; 1(8547):1428-9. PubMed ID: 2884513 [No Abstract] [Full Text] [Related]
37. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Mittler RS; Hoffmann MK Science; 1989 Sep; 245(4924):1380-2. PubMed ID: 2571187 [TBL] [Abstract][Full Text] [Related]
38. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects. Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054 [TBL] [Abstract][Full Text] [Related]
39. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246 [TBL] [Abstract][Full Text] [Related]
40. Obstacles to an AIDS vaccine. Barnes DM Science; 1988 May; 240(4853):719-21. PubMed ID: 2834823 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]